165 related articles for article (PubMed ID: 21219861)
1. Role of glycosaminoglycans of biglycan in BMP-2 signaling.
Miguez PA; Terajima M; Nagaoka H; Mochida Y; Yamauchi M
Biochem Biophys Res Commun; 2011 Feb; 405(2):262-6. PubMed ID: 21219861
[TBL] [Abstract][Full Text] [Related]
2. Recombinant biglycan promotes bone morphogenetic protein-induced osteogenesis.
Miguez PA; Terajima M; Nagaoka H; Ferreira JA; Braswell K; Ko CC; Yamauchi M
J Dent Res; 2014 Apr; 93(4):406-11. PubMed ID: 24482033
[TBL] [Abstract][Full Text] [Related]
3. Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation.
Ye Y; Hu W; Guo F; Zhang W; Wang J; Chen A
Int J Mol Med; 2012 Nov; 30(5):1075-80. PubMed ID: 22895561
[TBL] [Abstract][Full Text] [Related]
4. Identification of the effector domain of biglycan that facilitates BMP-2 osteogenic function.
Jongwattanapisan P; Terajima M; Miguez PA; Querido W; Nagaoka H; Sumida N; Gurysh EG; Ainslie KM; Pleshko N; Perera L; Yamauchi M
Sci Rep; 2018 May; 8(1):7022. PubMed ID: 29728612
[TBL] [Abstract][Full Text] [Related]
5. Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2.
Song R; Zeng Q; Ao L; Yu JA; Cleveland JC; Zhao KS; Fullerton DA; Meng X
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2711-20. PubMed ID: 22982459
[TBL] [Abstract][Full Text] [Related]
6. Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways.
Wang X; Harimoto K; Xie S; Cheng H; Liu J; Wang Z
Biol Pharm Bull; 2010; 33(11):1891-7. PubMed ID: 21048317
[TBL] [Abstract][Full Text] [Related]
7. Silencing of miR-330-5p stimulates osteogenesis in bone marrow mesenchymal stem cells and inhibits bone loss in osteoporosis by activating Bgn-mediated BMP/Smad pathway.
Jin SL; Bai YM; Zhao BY; Wang QH; Zhang HS
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4095-4102. PubMed ID: 32374006
[TBL] [Abstract][Full Text] [Related]
8. Lentiviral delivery of biglycan promotes proliferation and increases osteogenic potential of bone marrow-derived mesenchymal stem cells in vitro.
Wu B; Ma X; Zhu D; Liu Y; Sun Z; Liu S; Xue B; Du M; Yin X
J Mol Histol; 2013 Aug; 44(4):423-31. PubMed ID: 23504199
[TBL] [Abstract][Full Text] [Related]
9. Biglycan and chondroitin sulfate play pivotal roles in bone toughness via retaining bound water in bone mineral matrix.
Hua R; Ni Q; Eliason TD; Han Y; Gu S; Nicolella DP; Wang X; Jiang JX
Matrix Biol; 2020 Dec; 94():95-109. PubMed ID: 33002580
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Matrix Mediates BMP-2 in a Model of Temporomandibular Joint Osteoarthritis.
Shirakura M; Kram V; Robinson J; Sikka S; Kilts TM; Wadhwa S; Young MF
Cells Tissues Organs; 2017; 204(2):84-92. PubMed ID: 28419987
[TBL] [Abstract][Full Text] [Related]
11. Biglycan modulates angiogenesis and bone formation during fracture healing.
Berendsen AD; Pinnow EL; Maeda A; Brown AC; McCartney-Francis N; Kram V; Owens RT; Robey PG; Holmbeck K; de Castro LF; Kilts TM; Young MF
Matrix Biol; 2014 Apr; 35():223-31. PubMed ID: 24373744
[TBL] [Abstract][Full Text] [Related]
12. The small leucine-rich proteoglycan biglycan modulates BMP-4-induced osteoblast differentiation.
Chen XD; Fisher LW; Robey PG; Young MF
FASEB J; 2004 Jun; 18(9):948-58. PubMed ID: 15173106
[TBL] [Abstract][Full Text] [Related]
13. Mmu-miR-185 depletion promotes osteogenic differentiation and suppresses bone loss in osteoporosis through the Bgn-mediated BMP/Smad pathway.
Cui Q; Xing J; Yu M; Wang Y; Xu J; Gu Y; Nan X; Ma W; Liu H; Zhao H
Cell Death Dis; 2019 Feb; 10(3):172. PubMed ID: 30787286
[TBL] [Abstract][Full Text] [Related]
14. UV irradiation-induced production of monoglycosylated biglycan through downregulation of xylosyltransferase 1 in cultured human dermal fibroblasts.
Jin CL; Oh JH; Han M; Shin MK; Yao C; Park CH; Jin ZH; Chung JH
J Dermatol Sci; 2015 Jul; 79(1):20-9. PubMed ID: 25936869
[TBL] [Abstract][Full Text] [Related]
15. Biglycan-deficient mice have delayed osteogenesis after marrow ablation.
Chen XD; Allen MR; Bloomfield S; Xu T; Young M
Calcif Tissue Int; 2003 May; 72(5):577-82. PubMed ID: 12724831
[TBL] [Abstract][Full Text] [Related]
16. Biglycan modulates osteoblast differentiation and matrix mineralization.
Parisuthiman D; Mochida Y; Duarte WR; Yamauchi M
J Bone Miner Res; 2005 Oct; 20(10):1878-86. PubMed ID: 16160746
[TBL] [Abstract][Full Text] [Related]
17. Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice.
Tang T; Thompson JC; Wilson PG; Nelson C; Williams KJ; Tannock LR
Connect Tissue Res; 2013; 54(1):5-13. PubMed ID: 22834985
[TBL] [Abstract][Full Text] [Related]
18. N-methyl pyrrolidone as a potent bone morphogenetic protein enhancer for bone tissue regeneration.
Miguel BS; Ghayor C; Ehrbar M; Jung RE; Zwahlen RA; Hortschansky P; Schmoekel HG; Weber FE
Tissue Eng Part A; 2009 Oct; 15(10):2955-63. PubMed ID: 19320543
[TBL] [Abstract][Full Text] [Related]
19.
Cho TH; Kim IS; Lee B; Park SN; Ko JH; Hwang SJ
Tissue Eng Part A; 2017 Dec; 23(23-24):1343-1360. PubMed ID: 28457207
[TBL] [Abstract][Full Text] [Related]
20. Osteogenesis on nanoparticulate mineralized collagen scaffolds via autogenous activation of the canonical BMP receptor signaling pathway.
Ren X; Bischoff D; Weisgerber DW; Lewis MS; Tu V; Yamaguchi DT; Miller TA; Harley BA; Lee JC
Biomaterials; 2015 May; 50():107-14. PubMed ID: 25736501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
